HCV

Webinar Reflection: Integrated Care for Syndemics, Bringing SUD, HIV & HCV Treatment Together

ISSUP hosted a webinar on 4 December 2025 with Dr Sarah Kattakuzhy, exploring integrated care for the syndemic of SUD, HIV, and HCV. She highlighted that these conditions often occur together and intensify one another, making siloed approaches ineffective. The session showcased strong evidence that integrated care models; whether co-located, mobile, telemedicine-supported, or provider-integrated; improve uptake, viral suppression, and HCV cure rates. Case studies illustrated how person-centred, joined-up care strengthens trust, stability, and quality of life. The discussion emphasized the significant opportunity to scale integrated, flexible, and humane care models across diverse health systems.

HIV Prevention, Treatment, Care and Support for People Who Use Stimulant Drugs

Toolkit

Since the beginning of the HIV epidemic, the focus on HIV prevention, treatment and care among people who use drugs has concentrated on the needs of people who inject drugs, and mainly on those who inject opioids. However, data show that...

Peer-facilitated treatment access for hepatitis C: The Live Hep C Free project

Scientific article

This article explores the lessons learned during the implementation of a peer-facilitated hepatitis C virus hepatitis C testing and treatment access project called the Live Hep C Free project in contributing to micro-elimination efforts...

Call for Proposals: Prevention of hepatitis C among key populations

Unitaid is soliciting proposals that aim to catalyze the integration of HCV prevention and

Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients

Scientific article

21 April 2021

Abstract Background: The impact of Hepatitis C virus (HCV) RNA levels on the evolution of chronic HCV infection-related liver damage is controversial. Heavy alcohol use is believed to have a deleterious impact on the course of HCV disease...

HepHIV 2021

5 May 2021

Lisbon

The next HepHIV conference will take place 5-7 May 2021 involving participants from across the community, public health and the health system. Due to the COVID-19 pandemic, the HepHIV2021 Lisbon Conference will take place via a virtual platform. A Portuguese national meeting will be arranged if feasible.

EU HCV Elimination Policy Summit

24 March 2021

Online

Despite the progress that has been made in recent years, HCV remains a major public health problem in Europe. In the European Union (EU) more people die each year from HCV than from HIV/AIDS.

Inactivation of HCV and HIV by Microwave: A Novel Approach for Prevention of Virus Transmission among People who Inject Drugs

Scientific article

18 November 2016

Abstract Hepatitis C virus (HCV) and human immunodeficiency virus (HIV-1) transmissions among people who inject drugs (PWID) continue to pose a challenging global health problem. Here, we aimed to analyse a universally applicable...

Mobile Technology to Increase HIV/HCV Testing and Overdose Prevention/Response among People Who Inject Drugs

Scientific article

23 August 2017

The United States faces dramatically increasing rates of opioid overdose deaths, as well as persistent ongoing problems of undiagnosed HIV and HCV infection. These problems commonly occur together in substance using populations that have...

State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs — United States, 2015–2016

Scientific article

12 May 2017

Summary What is already known about this topic? The United States has experienced a sharp increase in hepatitis C virus (HCV) incidence that can be attributed to injection drug use. Some states have used public health laws and treatment...